Carlsmed (CARL) Accumulated Expenses (2024 - 2026)

Carlsmed (CARL) has 3 years of Accumulated Expenses data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (changed N/A YoY), and the FY2025 full-year result was $1.8 million, down 45.17% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $1.9 million, up from $1.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.3 million in Q4 2024 and bottomed at $1.8 million in Q4 2025.
• The 3-year median for Accumulated Expenses is $3.1 million (2025), against an average of $2.6 million.
• Peak annual rise in Accumulated Expenses reached 45.17% in 2025, while the deepest fall reached 45.17% in 2025.
• A 3-year view of Accumulated Expenses shows it stood at $3.3 million in 2024, then sank by 45.17% to $1.8 million in 2025, then grew by 3.63% to $1.9 million in 2026.
• The last three Accumulated Expenses figures came in at $1.9 million (Q1 2026), $1.8 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison